-+ 0.00%
-+ 0.00%
-+ 0.00%
ChemDAQ and Proline Medical Partner to Expand Access to Continuous Chemical Vapor Monitoring in Australian Hospitals
Share
Listen to the news

Partnership Formed as Australia Prepares to Adopt New Workplace Exposure Limits on 1 December 2026

PITTSBURGH, Sept. 30, 2026 /PRNewswire/ -- ChemDAQ, a leading provider of hazardous gas monitoring solutions, is pleased to announce a new partnership with Proline Medical, an Australian healthcare company specialising in infection prevention, sterilization, endoscopy and reprocessing solutions, with a strong national presence across hospitals and healthcare facilities.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending